ravi mazumdar's most recent trade in Syngene International Ltd. was a Acquisition of 6,686 Equity Shares done at an average price of Rs. 578.3 . Disclosure was reported to the exchange on Sept. 12, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for ravi mazumdar in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Syngene Intl | Ravi Mazumdar | Promoter Group | Acquisition | 12 Sep 2022 | 6,686 | 8,806 (0%) | 0.00% | 578.3 | 3,866,848 | 05 Sep 2022 05 Sep 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |
Biocon | Ravi Rasendra Mazumdar | Promoter Group | Acquisition | 12 Sep 2022 | 486,237 | 5,301,321 (0.44%) | 0.04% | 292.8 | 142,370,194 | 05 Sep 2022 05 Sep 2022 |
Insider Trading | Equity Shares | Inter-se Transfer |